Implementation of an opioid-sparing protocol utilizing liposomal bupivacaine and intravenous ketorolac for pain management after living kidney donation
A multimodal, opioid-sparing pain management protocol was as effective for pain control and resulted in significantly less opioid daily exposure over LOS. No adverse events were found related to use of ketorolac in patients undergoing donor nephrectomy. Our findings suggest that an opioid-sparing protocol is both safe and effective at minimizing opioid exposure and managing post-operative pain within the first 48 hours post-surgery.
Authors
- Daohai Yu (ORCID: https://orcid.org/0000-0003-1034-3130)
- Francesca Graziano (ORCID: https://orcid.org/0000-0001-8754-6572)
- Ina Ly (ORCID: https://orcid.org/0000-0003-0494-2946)
- Nicole M. Sifontis
- Sunil Karhadkar (ORCID: https://orcid.org/0000-0001-7943-0203)
- Kenneth D. Chavin (ORCID: https://orcid.org/0000-0003-0818-4847)
- Adam Diamond (ORCID: https://orcid.org/0000-0002-0319-4627)
- Xiaoning Lu
- Antonio Di Carlo (ORCID: https://orcid.org/0000-0002-0516-5483)
- Kelley Maberry
Institutions
- Temple University (US)
Publication Details
- Journal
- World Journal of Transplantation
- Published
- 2025-04-18
- DOI
- https://doi.org/10.5500/wjt.v15.i3.101518
- Citations
- 1
- Primary Topic
- Anesthesia and Pain Management
- Type
- article
- Field-Weighted Citation Impact
- 2.01